Monday, January 13, 2020

Human Longevity Sells Off Division For $37M

San Diego-based precision health analytics developer Human Longevity announced this morning that it has sold off its Oncology Division to NeoGenomics, in a deal worth $37M in cash. According to Human Longevity, the deal will help it focus entirely on "longevity and extending the healthy, high-performance human lifespan". The deal closed on Friday. Human Longevity's backers include Celgene, GE, and Illumina. The company said the sale--along with a Series A2 round of financing--will help it growth domestically and internationally. The company was co-founded by genetics pionner J. Craig Venter.